Essence of evidence-based medicine: A case report

被引:16
作者
Browman, GP
机构
[1] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hlth Informat Res Unit, Hamilton, ON, Canada
[2] McMaster Univ, Fac Hlth Sci, Program Evidence Based Care, Canc Care Ontario, Hamilton, ON, Canada
关键词
D O I
10.1200/JCO.1999.17.7.1969
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To illustrate the complexities of the evidence-based approach in clinical oncology practice and the implications for guidelines and evaluation of processes of core. Patient and Methods: A case report is presented in which a limited systematic review of the literature was used to address a specific clinical problem in an individual patient. Experts' opinions were also sought. Results: A reasonable clinical decision was made by a participating patient based on indirect evidence of benefit that would be insufficient to support the same decision as a health policy in some jurisdictions. Conclusion: The practice of evidence-based oncology requires clinical judgment about the validity and applicability of research evidence. The factors that influence an evidence based decision in the clinical context differ from those in the broader policy context, which could lead to legitimate differences in recommendations based on the same information. Used properly, the individual case report can be a powerful tool to illustrate complex clinical decision phenomena. (C) 1999 by American Society of Clinical Oncology.
引用
收藏
页码:1969 / 1973
页数:5
相关论文
共 32 条
[1]  
Adami S, 1989, Recent Results Cancer Res, V116, P67
[2]  
Adami S, 1997, CANCER, V80, P1674, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1674::AID-CNCR18>3.3.CO
[3]  
2-D
[4]  
[Anonymous], ANN ONCOL
[5]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[6]   Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, M ;
Blacklock, H ;
Bell, R ;
Simeone, JF ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :593-602
[7]   Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review [J].
Bloomfield, DJ .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1218-1225
[8]   Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin [J].
Bolla, M ;
Gonzalez, D ;
Warde, P ;
Dubois, JB ;
Mirimanoff, RO ;
Storme, G ;
Bernier, J ;
Kuten, A ;
Sternberg, C ;
Gil, T ;
Collette, L ;
Pierart, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05) :295-300
[9]  
Browman G P, 1997, Cancer Prev Control, V1, P7
[10]   DISODIUM PAMIDRONATE IDENTIFIES DIFFERENTIAL OSTEOCLASTIC BONE-RESORPTION IN METASTATIC PROSTATE-CANCER [J].
CLARKE, NW ;
MCCLURE, J ;
GEORGE, NJR .
BRITISH JOURNAL OF UROLOGY, 1992, 69 (01) :64-70